141 results on '"Stobart, Hilary"'
Search Results
2. ASO Visual Abstract: Understanding Patient Experiences to Inform Future Studies to Optimize Personalization of Treatment for Early Breast Cancer
3. DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS
4. The Lancet Breast Cancer Commission
5. Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind Alliance
6. The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project
7. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
8. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
9. The Lancet Breast Cancer Commission
10. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
11. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
12. European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer
13. Atypia detected during breast screening and subsequent development of cancer: observational analysis of the Sloane atypia prospective cohort in England
14. Evidence-informed recommendations on managing breast screening atypia: perspectives from an expert panel consensus meeting reviewing results from the Sloane atypia project
15. Investigating harms of testing for ovarian cancer – psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study.
16. Investigating harms of testing for ovarian cancer - psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: a cohort study embedded in the multicentre ROCkeTS prospective diagnostic study
17. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
18. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
19. The LancetBreast Cancer Commission
20. Evidence-informed recommendations on managing breast screening atypia: perspectives from an expert panel consensus meeting reviewing results from the Sloane atypia project.
21. Microcalcification crystallography as a potential marker of DCIS recurrence
22. Breast symptomatic service: Referral numbers and cancer diagnoses by age and sex in England 2019/20
23. Age and sex can predict cancer risk in people referred with breast symptoms
24. Abstract OT3-20-02: SMALL: Open Surgery versus Minimally invasive vacuum-Assisted excision for smaLL screen-detected breast cancer – a UK phase III randomised multi-centre trial
25. Abstract P6-05-17: Recruitment challenges in a UK surgical de-escalation study: preliminary qualitative research findings from the SMALL trial
26. (Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer.
27. Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement
28. The Importance of Quality Patient Advocacy to Biobanks: A Lay Perspective from Independent Cancer Patients Voice (ICPV), Based in the United Kingdom
29. Abstract PR002: Genomic predictor can discriminate between high- and low-risk DCIS
30. Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia
31. Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer".
32. Microcalcification crystallography as a potential marker of DCIS recurrence.
33. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study
34. Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind Alliance
35. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
36. Abstract 5108: Copy number analysis of pure DCIS and association with recurrence
37. SMALL: Open surgery versus minimally invasive vacuum-assisted excision for small screen-detected breast cancers.
38. Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort
39. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
40. The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge
41. The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge
42. Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort
43. Abstract P1-22-06: A longitudinal cohort study of outcomes in 311 women with unresected ductal carcinoma in situ detected through the English breast screening programme
44. Abstract P3-12-36: The diagnosis and prognosis of ductal carcinoma in situ (DCIS) with microinvasion - Results from the United Kingdom Sloane project
45. Abstract P1-22-01: Predictors of inaccurate pre-operative size assessment of screen detected DCIS and impact on recurrence rates
46. Abstract OT1-06-02: SMALL - Open surgery versus minimally invasive vacuum-assisted excision for small screen detected breast cancer: A phase 3 randomised trial
47. Abstract OT2-05-01: The HER2-RADiCAL study (Response ADaptive CAre pLan) - Tailoring treatment for HER2 positive early breast cancer
48. Abstract GS3-06: Primary results of the cTRAK TN trial: A clinical trial utilising ctDNA mutation tracking to detect minimal residual disease and trigger intervention in patients with moderate and high risk early stage triple negative breast cancer
49. Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study
50. Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.